Advent Life Sciences is a venture teams investing in life sciences businesses.
Business Model: B2B
Revenue: $3.4M
Employees: 11-50
Address: 158-160 North Gower Street
City: London
State: england
Zip: NW1 2ND
Country: GB
Advent Life Sciences is a venture teams investing in life sciences businesses.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
1/2012 | CN Creative | Series A | 3.1M |
5/2017 | Iterum Therapeutics | Series B | 65M |
1/2020 | AviadoBio | Seed Round | 15.9M |
2/2016 | Vestagen Technical Textiles | Venture Round | 7M |
9/2011 | Acutus Medical | Series A | 5.5M |
2/2022 | Nalu Medical | Venture Round | 0 |
10/2020 | Rappta Therapeutics | Series A | 10.6M |
12/2021 | AviadoBio | Series A | 0 |
8/2020 | F2G | Private Equity Round | 0 |
6/2022 | Proximie | Series C | 0 |
4/2020 | Zikani Therapeutics | Series A | 0 |
12/2013 | Vestagen Technical Textiles | Series A | 7.3M |
4/2020 | PIC Therapeutics | Seed Round | 5M |
10/2017 | Vestagen Technical Textiles | Venture Round | 0 |
4/2019 | Arrakis Therapeutics | Series B | 75M |
9/2015 | Vestagen Technical Textiles | Convertible Note | 3.3M |
3/2021 | Amphista Therapeutics | Series B | 0 |
9/2015 | Artax Biopharma | Series B | 10M |
8/2018 | KaNDy Therapeutics | Series C | 32.6M |
9/2022 | Tridek-One | Venture Round | 0 |
6/2002 | Infinity Pharmaceuticals | Series B | 0 |
9/2005 | Algeta | Series A | 28.9M |
3/2021 | Aura Biosciences | Venture Round | 0 |
2/2017 | Arrakis Therapeutics | Series A | 38M |
5/2022 | Artax Biopharma | Venture Round | 0 |
1/2017 | NeRRe Therapeutics | Series B | 28.6M |
2/2014 | Versartis | Series E | 55M |
12/2015 | Axonics Modulation Technologies | Series B | 0 |
6/2016 | F2G | Series E | 60M |
4/2018 | Zikani Therapeutics | Venture Round | 0 |
3/2016 | Acutus Medical | Series C | 75M |
6/2022 | Wondr Medical | Seed Round | 0 |
8/2022 | Moximed | Series C | 0 |
4/2020 | Amphista Therapeutics | Series A | 0 |
1/2001 | TandemLife | Venture Round | - |
5/1999 | KuDOS Pharmaceuticals Ltd | Series A | - |
3/2016 | Capella BioScience | Series A | 15.5M |
3/2015 | Aura Biosciences | Series B | 0 |
7/2016 | Aleta Biotherapeutics | Venture Round | - |
7/2015 | Nalu Medical | Venture Round | 11.9M |
1/2015 | GMP Orphan | Series A | - |
12/2017 | Aura Biosciences | Series C | 0 |
8/2013 | Vestagen Technical Textiles | Venture Round | 0 |
3/2017 | Moximed | Series C | 50M |
11/2012 | CardiAQ Valve Technologies | Series B | 37.3M |
6/2019 | Tridek-One | Venture Round | 3.4M |
10/2014 | Levicept | Series A | 16.1M |
2/2021 | Highlight Therapeutics | Venture Round | 0 |
5/2017 | Axonics Modulation Technologies | Series C | 0 |
6/2022 | MiroBio | Series B | 0 |
10/2019 | MiroBio | Series A | 33.2M |
10/2022 | PIC Therapeutics | Series A | 35M |
12/2006 | Conatus Pharmaceuticals | Venture Round | 6.6M |
7/2021 | NeRRe Therapeutics | Series B | 0 |
1/2015 | Calcico Therapeutics | Venture Round | - |
4/2022 | Epitopea | Seed Round | 0 |
6/2022 | MiroBio | Series B | 0 |
6/2022 | Wondr Medical | Seed Round | 0 |
6/2022 | Proximie | Series C | 0 |
5/2022 | Artax Biopharma | Venture Round | 0 |
4/2022 | Epitopea | Seed Round | 0 |
2/2022 | Nalu Medical | Venture Round | 0 |
12/2021 | AviadoBio | Series A | 0 |
7/2021 | NeRRe Therapeutics | Series B | 0 |
3/2021 | Aura Biosciences | Venture Round | 0 |
3/2021 | Amphista Therapeutics | Series B | 0 |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|